VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma
Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s intellectual property for the development of a new Campylobacter jejuni vaccine for humans. C. jejuni is one of the most…